InsiderTrades

Form 4 for AGL agilon health, inc.

Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-24 · accession 0001209191-22-039598 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-28 2022-06-24 AGL Desai Veeral Chief Strategy, Dev. Off S - Sale+OE $22.50 -106.4K 278.2K -28% -$2.39M
D 2022-06-28 2022-06-24 AGL Desai Veeral Chief Strategy, Dev. Off M - OptEx $1.00 +106.4K 384.6K +38% +$106.4K
D 2022-06-28 2022-06-24 AGL Desai Veeral Chief Strategy, Dev. Off M - OptEx $0.00 -106.4K 456.3K -19% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-24 S D 106,357 $22.50 278,211 D — — (F1) Includes restricted stock units.
2 Common Common Stock 2022-06-24 M A 106,357 $1.00 384,568 D — — (F1) Includes restricted stock units.
3 Derivative Options (Rights to Buy) 2022-06-24 M D 106,357 $0.00 456,280 D $1.00 · — to 2027-04-27 106,357 Common Stock (F3) These options were granted on April 27, 2017 and fully vested on April 27, 2021.